OBSERVATIONAL STUDY OF ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) CONVERTING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)

被引：0
|
作者：
Lunde, Martin [1 ]
Jackson, James [2 ]
Lunacsek, Orsolya [2 ]
Bailey, Robert A. [3 ]
Senbetta, Mekre
McKenzie, R. Scott [3 ]
机构：
[1] Twin Cities Clin Res, Minneapolis, MN USA
[2] Xcenda LLC, Palm Harbor, FL USA
[3] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2011年 / 57卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
176
引用
收藏
页码：A60 / A60
页数：1
相关论文
共 50 条
  • [1] HEMATOLOGIC OUTCOMES AND DOSING PATTERNS IN ANEMIC PATIENTS WITH PRE-DIALYSIS CHRONIC KIDNEY DISEASE (CKD) SWITCHING FROM DARBEPOETIN ALFA (DARB) TO EPOETIN ALFA (EPO)
    Hura, Claudia
    Jackson, James
    Lunacsek, Orsolya
    Bailey, Robert A.
    McKenzie, R. Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A65 - A65
  • [2] Hospital inpatient utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in patients with cancer and pre-dialysis chronic kidney disease (PCKD)
    Smith, J
    He, J
    Mahoney, A
    Noone, P
    Watson, S
    Mody, S
    McKenzie, RS
    VALUE IN HEALTH, 2006, 9 (03) : A105 - A105
  • [3] Epoetin alfa and darbepoetin alfa dosing patterns in anemic pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, RS
    Bookhart, B
    VALUE IN HEALTH, 2006, 9 (03) : A96 - A96
  • [4] Epoetin alfa and darbepoetin alfa dosing trends in pre-dialysis chronic kidney disease patients
    Mody, S
    Padmanabhan, V
    McKenzie, S
    Piech, CT
    VALUE IN HEALTH, 2005, 8 (03) : 416 - 416
  • [5] Epoetin alfa and darbepoetin alfa dosing patterns and drug costs in patients with pre-dialysis chronic kidney disease
    Lefevbre, P
    Mody, SH
    McKenzie, RS
    Bookhart, B
    Duh, MS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A39 - A39
  • [6] Epoetin alfa and darbepoetin alfa dosing trends and drug costs in elderly pre-dialysis chronic kidney disease patients
    Mody, S.
    Padmanabhan, V
    Bookhart, B.
    Mckenzie, R. S.
    VALUE IN HEALTH, 2007, 10 (03) : A12 - A13
  • [7] Utilization of epoetin alfa (EPO) and darbepoetin alfa (DARB) in critically ill patients.
    Mody, S.
    Watson, S.
    McKenzie, R. S.
    Raut, M.
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A131 - A131
  • [8] Impact of epoetin alfa (EPO) on progression to dialysis in elderly chronic kidney disease (CKD) patients
    Duh, MS
    Mody, SH
    Lefebvre, P
    Bookhart, B
    Bourezak, A
    Piech, CT
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A27 - A27
  • [9] EPOETIN ALFA (EPO) UTILIZATION TRENDS IN MEDICARE PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) NOT ON DIALYSIS
    Kokkotos, Fotios
    Bailey, Robert A.
    Kerr, Matthew
    Shen, Sherlynn
    Senbetta, Mekre
    McKenzie, R. Scott
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A41 - A41
  • [10] CONVERSION FROM EPOETIN ALFA TO DARBEPOETIN ALFA IN HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE: FRENCH MONOCENTRE OBSERVATIONAL STUDY
    Binaut, R.
    Bacri, J. L.
    Fleury, D.
    Maisonneuve, N.
    Labatut, D.
    Lemaitre, V
    Medeghri, Z.
    Bir, G.
    Lanier, J.
    VALUE IN HEALTH, 2012, 15 (07) : A458 - A459
12345